Article
Different histopathology but the same clonality: ALK rearrangement in a patient with metastatic non-small-cell lung cancer.
International journal of clinical and experimental pathology - 1 Jan 2015
Zhao Jing, Zhou Jianya, Chen Zhen, Wang Bo, Zhang Xiuming, Zhou Jianying, Ding Wei
Abstract excerpt
EML4-ALK rearrangement is detected in 2% to 7% of lung adenocarcinomas, these tumors are sensitive to crizotinib. The histologic feature of ALK translocated non-small-cell lung cancer (NSCLC) has been studied, presence of signet-ring cells was a powerful histologic indicator of ALK rearrangement,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
